Public Profile

Otsuka Pharmaceutical

Otsuka Pharmaceutical Co., Ltd., commonly referred to as Otsuka, is a leading global healthcare company headquartered in Japan. Established in 1964, Otsuka has made significant strides in the pharmaceutical and nutraceutical industries, focusing on innovative solutions for mental health, oncology, and general healthcare. With a strong presence in regions such as North America, Europe, and Asia, Otsuka is renowned for its unique products, including the antipsychotic medication Abilify and the hydration solution Pocari Sweat. The company’s commitment to research and development has positioned it as a pioneer in addressing unmet medical needs. Otsuka's dedication to innovation and patient care has earned it a notable reputation in the global market, making it a key player in the pharmaceutical landscape.

DitchCarbon Score

How does Otsuka Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

72

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Otsuka Pharmaceutical's score of 72 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

99%

Let us know if this data was useful to you

Otsuka Pharmaceutical's reported carbon emissions

In 2023, Otsuka Pharmaceutical reported total carbon emissions of approximately 776,000,000 kg CO2e, comprising 109,739,000 kg CO2e from Scope 1, 1,395,000 kg CO2e from Scope 2, and 664,646,000 kg CO2e from Scope 3 emissions. This reflects a commitment to transparency in their emissions reporting across all scopes. The company has set a long-term goal to achieve "Net Zero" emissions by 2050, as part of its 2050 Environmental Vision. This initiative aims to reduce the total environmental impact of its business activities to zero. To support this vision, Otsuka is implementing an integrated energy service structure under a retail electricity provider model, which is expected to enhance energy efficiency and sustainability. In previous years, Otsuka's emissions have shown fluctuations, with total emissions of approximately 763,050,000 kg CO2e in 2021 and 785,684,000 kg CO2e in 2020. The company continues to focus on reducing its carbon footprint and enhancing its sustainability practices across all operations.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2011201220172020202120222023
Scope 1
285,728,000
000,000,000
-
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
116,816,000
000,000,000
-
00,000,000
0,000,000
0,000,000
0,000,000
Scope 3
402,544,000
000,000,000
-
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Otsuka Pharmaceutical's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Otsuka Pharmaceutical is in JP, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Otsuka Pharmaceutical is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Lundbeck

DK
Pharmaceutical Preparation Manufacturing
Updated about 16 hours ago

Traphaco Joint Stock Company

VN
Pharmaceutical Preparation Manufacturing
Updated about 23 hours ago

Indivior

US
Pharmaceutical Preparation Manufacturing
Updated about 16 hours ago

Allergan, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated about 23 hours ago

Sandoz International GmbH

DE
Pharmaceutical Preparation Manufacturing
Updated about 23 hours ago

Domesco Medical Import - Export Joint-Stock Corporation

VN
Pharmaceutical Preparation Manufacturing
Updated about 23 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers